IRIS
TARANTINO, GIOVANNI
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.533
EU - Europa 763
AS - Asia 322
AF - Africa 34
OC - Oceania 3
SA - Sud America 2
Totale 2.657
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.499
CN - Cina 260
IT - Italia 202
NL - Olanda 141
FI - Finlandia 118
IE - Irlanda 96
DE - Germania 88
UA - Ucraina 56
VN - Vietnam 44
CA - Canada 34
CI - Costa d'Avorio 34
SE - Svezia 31
GB - Regno Unito 20
TR - Turchia 7
IN - India 5
AU - Australia 3
BE - Belgio 3
FR - Francia 3
SG - Singapore 3
AL - Albania 1
AR - Argentina 1
BA - Bosnia-Erzegovina 1
CO - Colombia 1
GR - Grecia 1
IL - Israele 1
RS - Serbia 1
SA - Arabia Saudita 1
TH - Thailandia 1
VA - Santa Sede (Città del Vaticano) 1
Totale 2.657
Salva come PNG Salva come JPEG
Città #
Chandler 318
Amsterdam 132
Princeton 113
Jacksonville 97
Millbury 96
Nanjing 80
Boston 72
Napoli 67
Des Moines 47
Beijing 45
Dong Ket 44
Ashburn 41
Naples 40
Wilmington 37
Ottawa 33
Nanchang 29
Shenyang 20
Hebei 19
Norwalk 14
Tianjin 13
Jiaxing 11
Changsha 10
Kunming 10
Falls Church 9
Kronberg 9
Lawrence 9
Boardman 8
Dearborn 7
Catania 5
Hangzhou 5
Seattle 5
Washington 5
Fairfield 4
Köln 4
Melfi 4
New York 4
Redwood City 4
Augusta 3
Courcelles 3
Frankfurt am Main 3
Helsinki 3
Nocera Inferiore 3
Oliveto Citra 3
Pune 3
Redmond 3
Zhengzhou 3
Brisbane 2
Changchun 2
Cologne 2
Dublin 2
Hefei 2
Milan 2
Orange 2
Rome 2
Shanghai 2
Singapore 2
Somma Vesuviana 2
Woodbridge 2
Wuhan 2
Battipaglia 1
Belgrade 1
Brescia 1
Buenos Aires 1
Buffalo 1
Chicago 1
Crick 1
Eindhoven 1
Ercolano 1
Guangzhou 1
Indiana 1
Jinan 1
Krefeld 1
Lanzhou 1
London 1
Massa 1
Medellín 1
Melito di Napoli 1
Nashville 1
Ningbo 1
Potenza 1
Procida 1
Salerno 1
San Mateo 1
Sarajevo 1
Shefa-'Amr 1
Stanford 1
Suffern 1
Sydney 1
Tappahannock 1
Toronto 1
Torre Del Greco 1
Zhongxin 1
Totale 1.556
Salva come PNG Salva come JPEG
Nome #
Nutrition: a key environmental dietary factor in clinical severity and cardio-metabolic risk in psoriatic male patients evaluated by 7-day food-frequency questionnaire 58
Adherence to the Mediterranean Diet and Circulating Levels of Sirtuin 4 in Obese Patients: A Novel Association 50
Incidence of hypertension in individuals with different blood pressure salt-sensitivity: results of a 15-year follow-up study. 48
"obesity paradox" or "metabolically benign obesity"? 48
EC-MPS permits lower gastrointestinal symptom burden despite higher MPA exposure in patients with severe MMF-related gastrointestinal side-effects. 45
Quantification of sirolimus and everolimus by immunoassay techniques: test specificity and cross-reactivity evaluation 44
Analytical and pharmacological aspects of therapeutic drug monitoring of mTOR inhibitors 44
Analysis of extracellular superoxide dismutase in fibroblasts from patients with systemic sclerosis 44
UCP1 -3826 AG+GG genotypes, adiponectin, and leptin/adiponectin ratio in severe obesity. 41
Association of NAFLD and Insulin Resistance with Non Metastatic Bladder Cancer Patients: A Cross-Sectional Retrospective Study 40
Abnormally high resistive index of central retinal artery by ultrasound color Doppler in patients with viral chronic liver disease: correlation with worsening liver staging. 39
Stability of sirolimus and everolimus measured by immunoassay techniques in whole blood samples from kidney transplant patients 39
Could the depression of obese patients suffering from chronic hepatitis C be temporarily improved? 38
Hepatic steatosis, carotid plaques and achieving MDA in psoriaticarthritis patients starting TNF-alpha blockers treatment: a prospective study. 38
A prospective study of acute drug-induced liver injury in patients suffering from non-alcoholic fatty liver disease. 37
ARE HEPATIC STEATOSIS AND CAROTID INTIMA MEDIA THICKNESS ASSOCIATED IN OBESE PATIENTS WITH NORMAL OR SLIGHTLY ELEVATED GAMMA-GLUTAMYL-TRANSFERASE? 37
Hematocrit Values Predict Carotid Intimal-Media Thickness in Obese Patients With Non-Alcoholic Fatty Liver Disease: A Cross-Sectional Study 36
Non-alcoholic fatty liver disease: further expression of the metabolic syndrome. 35
Bisphenol-A plasma levels are related to inflammatory markers, visceral obesity and insulin-resistance: a cross-sectional study on adult male population. 35
Aspetti psico-sociali delle malattie allergiche 34
Comparison of the everolimus concentrations measured in whole blood with everolimus QMS or sirolimus CMIA 34
Basal metabolic rate in morbidly obese patients with non-alcoholic fatty liver disease. 33
Drug-induced liver injury due to "natural products" used for weight loss: a case report. 33
Absence of pharmacokinetic interference of moxifloxacin on cyclosporine and tacrolimus in kidney transplant recipients 33
BISPHENOL A IN POLYCYSTIC OVARY SYNDROME AND ITS ASSOCIATION WITH LIVER-SPLEEN AXIS. 33
Reticulocyte Hemoglobin Content Helps Avoid Iron Overload in Hemodialysis Patients: A Retrospective Observational Study 32
A pharmacokinetic interaction between clarithromycin and sirolimus in kidney transplant recipient 32
Circulating levels of sirtuin 4, a potential marker of oxidative metabolism, related to coronary artery disease in obese patients suffering from nafld, with normal or slightly increased liver enzymes 32
Non-alcoholic fatty liver disease in young adult severely obese non-diabetic patients in South Italy. 31
Enhanced serum concentrations of transfroming growth factor-beta 1 in simple fatty liver: it is really benign? 31
Long-term assessment of plasma lipids in transplant recipients treated with tacrolimus in relation to fatty liver. 31
Carotid intima-media thickness is predicted by combined eotaxin levels and severity of hepatic steatosis at ultrasonography in obese patients with nonalcoholic fatty liver disease 31
Sublingual administration improves systemic exposure of tacrolimus in kidney transplant recipients: comparison with oral administration 31
Should octreotide be used cautiously in liver cirrhosis with concomitant congestive heart failure correlated to coronary artery disease? 29
Blood ammonia levels in liver cirrhosis: a clue for the presence of portosystemic collateral veins. 29
Nonalcoholic fatty liver disease, spleen and psoriasis: New aspects of low-grade chronic inflammation 29
Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient. 28
Biomarkers of subclinical atherosclerosis in patients with psoriatic arthritis 28
Clinical presentation and prevalence of spontaneous bacterial peritonitis in patients with cryptogenic cirrhosis and features of metabolic syndrome. 27
Anti-cyclic citrullinated peptide antibodies in patients affected by HCV-related arthritis. 27
Nutrition, inflammation and liver-spleen axis 26
Does a lower insulin resistance affect antiviral therapy response in patients suffering from HCV related chronic hepatitis? 25
Could inflammatory markers help diagnose nonalcoholic steatohepatitis? 25
Noninvasive assessment of liver fibrosis in patients with chronic hepatitis C (and congenital bleeding disorders): where do we stand? 25
Omega-3 fatty acids for the treatment of non-alcoholic fatty liver disease 25
Clinical factors affecting prostate-specific antigen levels in prostate cancer patients undergoing radical prostatectomy: a retrospective study 25
A Comparative Study of the Triglycerides/HDL Ratio and Pseudocholinesterase Levels in Patients with Bladder Cancer 25
Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease. 25
Hepatic steatosis in overweight/obese females: new screening method for those at risk 24
Successful and safe long-term standard antiviral therapy in a patient with “Explosive” immune response in course of HCV-related liver cirrhosis 24
Low daily dosage of interferon for 1 year after HCV-related end-therapy response. A randomized-controlled study. 23
Does spleen volume play a role in patients with HCV-related chronic hepatitis? 23
Exposure to ambient air particulate matter and non-alcoholic fatty liver disease 23
Could the improvement of obesity-related co-morbidities depend on modified gut hormones secretion? 23
Exaggerated immune reactions predict the outcome of interferon therapy in patients with chronic hepatitis C. 22
Epatopatia e coagulazione 22
Preliminary data on the relationship between circulating levels of Sirtuin 4, anthropometric and metabolic parameters in obese subjects according to growth hormone/insulin-like growth factor-1 status 22
Hype or Reality: Should Patients with Metabolic Syndrome-related NAFLD be on the Hunter-Gatherer (Paleo) Diet to Decrease Morbidity? 22
Young adult obese subjects with and without insulin resistance: what is the role of chronic inflammation and how to weigh it non-invasively? . 21
Is the quality of life always depressed in patients with chronic hepatitis C on antiviral therapy? 21
Is serum Interleukin-17 associated with early atherosclerosis in obese patients? 21
Could metabolic syndrome lead to hepatocarcinoma via non-alcoholic fatty liver disease? 21
Liver-spleen axis: Intersection between immunity, infections and metabolism 21
Rheumatoid factor after antiviral therapy in patients with HCV chronic hepatitis. 20
Hepatic steatosis, low-grade chronic inflammation and hormone/growth factor/adipokine imbalance 20
Serum Bcl-2 concentrations in overweight-obese subjects with nonalcoholic fatty liver disease 20
The contribution of omental adipose tissue to adipokine concentrations in patients with the metabolic syndrome. 20
Positivity for anti-HCV antibodies among Italian hospitalized patients 19
Hepatitis C virus lymphotropism and peculiar immunological phenotype: effects on natural history and antiviral therapy. 19
Systematic review on intervention with prebiotics/probiotics in patients with obesity-related nonalcoholic fatty liver disease 19
Silent non-alcoholic fatty liver disease - A clinical-histological study 19
Can serum TGF-beta 1 be used to evaluate the response to antiviral therapy of haemophilic patients with HCV-related chronic hepatitis? 18
Successful lamivudine monotherapy in an elderly patient suffering from HBV-related decompensated cirrhosis associated with widespread leukocytoclastic vasculitis. 18
Serum 25-Hydroxyvitamin D Levels, Phosphoprotein Enriched in Diabetes Gene Product (PED/PEA-15) and Leptin-to-Adiponectin Ratio in Women with PCOS. 18
Abnormally high prevalence of major components of the metabolic syndrome in subjects with early-onset idiopathic venous thromboembolism 18
What about non-alcoholic fatty liver disease as a new criterion to define metabolic syndrome? 18
Do thyroid abnormalities detected in patients treated for HCV-related chronic hepatitis persist? 17
Insulin-like Growth Factor-1, Psoriasis, and inflammation: a mènage a trois 17
What is the role of adiponectin in obesity related non-alcoholic fatty liver disease? 17
Mental status impairment in patients with West Haven grade zero hepatic encephalopathy: the role of HCV infection. 16
Extensive psoriasis induced by pegylated interferon: a case report. 16
Is there a direct role of hepatitis C virus in portosystemic encephalopathy? 16
Pathogenesis of hepatic steatosis: The link between hypercortisolism and non-alcoholic fatty liver disease 16
What are the implications of the spontaneous spleno-renal shunts in liver cirrhosis? 15
What non-alcoholic fatty liver disease has got to do with obstructive sleep apnoea syndrome and viceversa? 15
Have guidelines addressing physical activity been established in nonalcoholic fatty liver disease? 15
Steatosis, steatohepatitis and cancer immunotherapy: An intricate story 15
From bed to bench: which attitude towards the laboratory liver tests should health care practitioners strike? 14
Should nonalcoholic fatty liver disease be regarded as a hepatic illness only? 14
Inhibition of the mTOR pathway: A possible protective role in coronary artery disease 14
Suggestive hypothesis on a case report: Patient presenting with cyclical ovarian cysts coupled to increased cholestatic enzymes 14
Serum concentrations of the tissue polypeptide specific antigen in patients suffering from non-alcoholic steatohepatitis 13
Utility of sonography in diagnosing hepatocellular carcinoma 13
Does protracted antiviral therapy impact on HCV-related liver cirrhosis progression? 13
Non-alcoholic fatty liver disease, obesity and other illnesses. 13
Evalutation of mycophenolic acid systemic exposure by limited sampling strategy in kidney transplant recipients receiving enteric-coated mycophenolate sodium (EC-MPS) and cyclosporine. 13
Flow cytometry assay of myeloid dendritic cells (mDCs) in peripheral blood during acute hepatitis C: possible pathogenetic mechanisms 13
New Avenues for Treatment and Prevention of Drug-Induced Steatosis and Steatohepatitis: Much More Than Antioxidants 13
Findings from studies are congruent with obesity having a viral origin, but what about obesity-related nafld? 13
Drug-induced liver injury: is it somehow foreseeable? 12
Totale 2.571
Salva come PNG Salva come JPEG
Categoria #
all - tutte 12.655
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 12.655
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201926 0 0 0 0 0 0 0 0 0 1 2 23
2019/2020301 136 9 18 0 13 6 2 0 6 19 50 42
2020/2021219 0 13 18 16 19 42 23 2 17 6 18 45
2021/2022618 3 1 7 1 4 23 7 22 102 24 158 266
2022/2023796 125 70 31 39 78 77 1 70 118 122 47 18
2023/2024359 25 109 78 33 20 22 11 51 5 5 0 0
Totale 2.828